title: Oxytocin and bone.
abstract: One of the most meaningful results recently achieved in bone research has been to reveal that the pituitary hormones have profound effect on bone, so that the pituitary-bone axis has become one of the major topics in skeletal physiology. Here, we discuss the relevant evidence about the posterior pituitary hormone oxytocin (OT), previously thought to exclusively regulate parturition and breastfeeding, which has recently been established to directly regulate bone mass. Both osteoblasts and osteoclasts express OT receptors (OTR), whose stimulation enhances bone mass. Consistent with this, mice deficient in OT or OTR display profoundly impaired bone formation. In contrast, bone resorption remains unaffected in OT deficiency because, even while OT stimulates the genesis of osteoclasts, it inhibits their resorptive function. Furthermore, in addition to its origin from the pituitary, OT is also produced by bone marrow osteoblasts acting as paracrine-autocrine regulator of bone formation modulated by estrogens. In turn, the power of estrogen to increase bone mass is OTR-dependent. Therefore, OTR(-/-) mice injected with 17β-estradiol do not show any effects on bone formation parameters, while the same treatment increases bone mass in wild-type mice. These findings together provide evidence for an anabolic action of OT in regulating bone mass and suggest that bone marrow OT may enhance the bone-forming action of estrogen through an autocrine circuit. This established new physiological role for OT in the maintenance of skeletal integrity further suggests the potential use of this hormone for the treatment of osteoporosis.
authors.affiliation: Department of Basic Medical Science, Neuroscience and Sense Organs, University of Bari, Bari, Italy; and graziana.colaianni@libero.it.
authors.forename: Graziana
authors.initials: G
authors.lastname: Colaianni
authors.affiliation: Mount Sinai Bone Program, Mount Sinai School of Medicine, New York, New York.
authors.forename: Li
authors.initials: L
authors.lastname: Sun
authors.affiliation: Mount Sinai Bone Program, Mount Sinai School of Medicine, New York, New York.
authors.forename: Mone
authors.initials: M
authors.lastname: Zaidi
authors.affiliation: Department of Basic Medical Science, Neuroscience and Sense Organs, University of Bari, Bari, Italy; and.
authors.forename: Alberta
authors.initials: A
authors.lastname: Zallone
mesh_terms: D000818:Animals; D019898:Autocrine Communication / Q000502:physiology*; D001842:Bone and Bones / Q000166:cytology / Q000502:physiology*; D004958:Estradiol / Q000494:pharmacology / Q000502:physiology; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D023421:Models, Animal; D010006:Osteoblasts / Q000166:cytology / Q000378:metabolism; D010010:Osteoclasts / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D010012:Osteogenesis / Q000187:drug effects / Q000502:physiology*; D010121:Oxytocin / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D018045:Receptors, Oxytocin / Q000378:metabolism
chemical_list: D018045:Receptors, Oxytocin; D004958:Estradiol; D010121:Oxytocin
keywords: bone; estrogen; hormones; osteoporosis; oxytocin